Since 1986 MetaSystems has been designing and manufacturing systems for computerized automated microscopic imaging. From the very beginning, the close relationship to the end user has been an essential part of the MetaSystems philosophy. The following three decades have revealed that this was a successful strategy; from humble beginnings, MetaSystems has grown into a leading solution provider which still remains connected to its strong roots.
MetaSystems’ latest innovation, Neon, is a dynamic, modern imaging platform which reliably manages cases, images, and results from single workstation environments to large multi-user, multi-site installations. The Neon imaging platform ensures that all relevant information is accessible whenever needed.
Maybe you can find a solution to your imaging automation problem here on this web site. We recommend starting your journey on the application pages, if you are not familiar with our product portfolio. In case you are, it may be easier to go directly to the page for the product you actually look for. Should you feel lost, please feel free to contact us or the MetaSystems partner in your country.
We believe in communication being the first step towards innovative solutions!
Radiological emergencies in which a large number of victims are involved can occur as the result of different events such as radiation accidents, terrorist attacks with dirty bombs or other kinds of exposure to radioactive sources. In the event of large radiological accidents, an initial triage aimed at classifying victims according to the degree of exposure is indicated to guide appropriate clinical responses. [...] The cytokinesis-block (CB) micronucleus (MN) assay, originally developed by Fenech and Morley in 1985, is a valuable biodosimetric tool for quantifying radiation-induced chromosomal damage for population triage thanks to the simplicity of MN scoring and the availability of automated MN analysis using microscopy-based [...] methods. [...] Five laboratories performed both automated and semi-automated MN scoring using the Metafer platform (Metasystems, Altlussheim, Germany). [...] The lowest level of inhomogeneity was obtained for the automated scoring group where a more standardized approach was applied. [...] The results of the two micronucleus intercomparison exercises performed by the RENEB network, demonstrate that the cytokinesis-block MN assay is a useful triage tool for large-scale
radiation emergencies.
Cited From: International journal of radiation biology (2017)
Read more...
All Publications
MetaSystems Probes now has its own website. If you are looking for MetaSystems XCyting DNA Probes, please visit the MetaSystems Probes website.
The Cancer Genomics Consortium annual summer meeting is a unique forum for education and discussion of best practices in laboratory genomics. The CGC is committed to advancing clinical diagnostics through the use of genomic technologies (microarray, massively parallel sequencing, etc.) and improving the data processing that accompanies these technologies.
The European Cytogeneticists Association (E.C.A) yearly meeting, the 11th European Cytogenetics Conference took place in Florence, Italy and MetaSystems was proud to be sponsor and exhibitor of this event. Visitors to the MetaSystems booth had the opportunity to see the current pre-release edition of Neon, probably the last one before the official product launch. Of course also MetaSystems Probes took the opportunity to provide cytogeneticists and other passersby to show and explain the newest probe kits and product lines. The German MetaSystems team has been actively supported by the colleagues from MetaSystems s.r.l. in Milan.
The growing success of microbiology related applications within the MetaSystems product portfolio led to the launch of MetaSystems Indigo, the new MetaSystems brand which unites all microbiology products under the same roof. The ASM 2017 show in New Orleans, LA (USA) has been the venue of the second MetaSystems Indigo presentation after the ECCMID 2017 in Europe.
Please select your country of residence. Choose International if your country is not listed.
Our internet site may contain information that is not approved in all countries or regions. To ensure accuracy of content, it is required that you select the site which is appropriate for your country of residence.
